MedTrace Logo

Universal Screening Program for Cytomegalovirus Infection in the First Trimester of Pregnancy (CITEMB Study)

NCT05699421 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3357

Last updated 2025-09-10

No results posted yet for this study

Summary

The aim of this study is to evaluate a universal cCMV screening programme in the first trimester of pregnancy in primary care in Catalonia (Spain).

Conditions

  • Screening

Interventions

OTHER

screening programme

CMV screening during the first trimester of pregnancy and neonatal

Sponsors & Collaborators

  • Vall d'Hebron Barcelona Hospital Campus

    collaborator UNKNOWN

  • Hospital Clínic Sede Maternitat

    collaborator OTHER

  • Germans Trias i Pujol Hospital

    collaborator OTHER

  • ASSIRs Barcelona

    collaborator UNKNOWN

  • ASSIRs Metropolitana Nord

    collaborator UNKNOWN

  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-21
Primary Completion
2024-12-31
Completion
2025-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05699421 on ClinicalTrials.gov